CytoDyn Statistics

Total Valuation

CytoDyn has a market cap or net worth of 288.56 million. The enterprise value is 295.97 million.

Market Cap	288.56M
Enterprise Value	295.97M

Important Dates

The next estimated earnings date is Thursday, April 10, 2025.

Earnings Date	Apr 10, 2025
Ex-Dividend Date	n/a

Share Statistics

CytoDyn has 1.23 billion shares outstanding. The number of shares has increased by 19.97% in one year.

Current Share Class	n/a
Shares Outstanding	1.23B
Shares Change (YoY)	+19.97%
Shares Change (QoQ)	+1.93%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	0.02%
Float	1.23B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-18.81
EV / Sales	n/a
EV / EBITDA	33.63
EV / EBIT	34.09
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.35

Current Ratio	0.35
Quick Ratio	0.33
Debt / Equity	n/a
Debt / EBITDA	3.27
Debt / FCF	n/a
Interest Coverage	1.40

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	31.81%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-18.98%
Revenue Per Employee	n/a
Profits Per Employee	-1.75M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.06% in the last 52 weeks. The beta is -0.29, so CytoDyn's price volatility has been lower than the market average.

Beta (5Y)	-0.29
52-Week Price Change	+38.06%
50-Day Moving Average	0.24
200-Day Moving Average	0.16
Relative Strength Index (RSI)	47.61
Average Volume (20 Days)	2,102,173

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.70

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	8.68M
Pretax Income	-14.25M
Net Income	-15.73M
EBITDA	8.70M
EBIT	8.68M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 21.34 million in cash and 28.74 million in debt, giving a net cash position of -7.41 million or -0.01 per share.

Cash & Cash Equivalents	21.34M
Total Debt	28.74M
Net Cash	-7.41M
Net Cash Per Share	-0.01
Equity (Book Value)	-89.39M
Book Value Per Share	-0.07
Working Capital	-45.99M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.13M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CytoDyn does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.97%
Shareholder Yield	-19.97%
Earnings Yield	-5.45%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a